Clinical trial
Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents
NCT00252278 · Rhode Island Hospital, Other · Unknown status
Key facts
| NCT number | NCT00252278 |
|---|---|
| Title | Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents |
| Official title | The Effect of a Once Daily Evening Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents |
| Lead sponsor | Rhode Island Hospital, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention-Deficit/Hyperactivity Disorder (ADHD), Insomnia |
| Intervention type | Drug |
| Interventions | atomoxetine |
| Enrollment | 36 |
| Start date | Nov 1, 2005 |
| First posted | Nov 11, 2005 |
| Last update posted | Jul 7, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: